Efficient mucosal transmissibility but limited pathogenicity of R5 SHIVSF162P3N in Chinese-Origin rhesus macaques

Journal of Acquired Immune Deficiency Syndromes

Volumn 62, Issue 5, 2013, Pages 496-504

  Mumbauer, Alexandra ^a   Gettie, Agegenhu ^a   Blanchard, James ^b   Cheng Mayer, Cecilia ^a  

^a AARON DIAMOND AIDS RESEARCH CENTER   (United States)

^b TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

Author keywords

AIDS; Mucosal transmission; Rhesus macaque subspecies; SHIV

Indexed keywords

CHEMOKINE RECEPTOR CCR5;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHINESE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; INOCULATION; MALE; MUCOSAL IMMUNITY; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; SURVIVAL RATE; VIRUS INFECTIVITY; VIRUS LOAD; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ANIMALS; CD4 LYMPHOCYTE COUNT; CHINA; COHORT STUDIES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DNA, VIRAL; FEMALE; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MACACA MULATTA; MALE; MUCOUS MEMBRANE; RANDOM ALLOCATION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIREMIA;

EID: 84876408087     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31827f1c11     Document Type: Article

References (52)

1. Hirsch VM, Lifson JD. Simian immunodeficiency virus infection of monkeys as a model system for the study of AIDS pathogenesis, treatment, and prevention. Adv Pharmacol. 2000;49:437-477.
2. Morgan C, Marthas M, Miller C, et al. The use of nonhuman primate models in HIV vaccine development. PLoS Med. 2008;5:e173.
3. Veazey RS, Shattock RJ, Johan Klasse P, et al. Animal models for microbicide studies. Curr HIV Res. 2012;10:79-87.
4. Van Rompay KKA. The use of nonhuman primate models of HIV infection for the evaluation of antiviral strategies. AIDS Res Hum Retroviruses. 2012;28:16-35.
5. Grossman Z, Picker LJ. Pathogenic mechanisms in simian immunodeficiency virus infection. Curr Opin HIV AIDS. 2008;3:380-386.
6. Haase AT. Targeting early infection to prevent HIV-1 mucosal transmission. Nature. 2010;464:217-223.
7. Letvin NL. Progress and obstacles in the development of an AIDS vaccine. Nat Rev Immunol. 2006;6:930-939.
8. Picker LJ, Hansen SG, Lifson JD. New paradigms for HIV/AIDS vaccine development. Annu Rev Med. 2012;63:95-111.
9. Sodora DL, Silvestri G. Immune activation and AIDS pathogenesis. AIDS. 2008;22:439-446.
10. Harouse JM, Gettie A, Tan RC, et al. Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs. Science. 1999;284:816-819.
11. Harouse JM, Gettie A, Eshetu T, et al. Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3). J Virol. 2001;75:1990-1995.
12. Harouse JM, Buckner C, Gettie A, et al. CD8+ T cell-mediated CXC chemokine receptor 4-simian/human immunodeficiency virus suppression in dually infected rhesus macaques. Proc Natl Acad Sci U S A. 2003;100:10977-10982.
13. Tasca S, Tsai L, Trunova N, et al. Induction of potent local cellular immunity with low dose X4 SHIVSF33A vaginal exposure. Virology. 2007;367:196-211.
14. Trunova N, Tsai L, Tung S, et al. Progestin-based contraceptive suppresses cellular immune responses in SHIV-infected rhesus macaques. Virology. 2006;352:169-177.
15. Boadi T, Schneider E, Chung S, et al. Cellulose acetate 1, 2-benzenedicarboxylate protects against challenge with pathogenic X4 and R5 simian/human immunodeficiency virus. AIDS. 2005;19:1587-1594.
16. Cheng-Mayer C, Huang Y, Gettie A, et al. Delay of simian human immunodeficiency virus infection and control of viral replication in vaccinated macaques challenged in the presence of a topical microbicide. AIDS. 2011;25:1833-1841.
17. Keele BF, Giorgi EE, Salazar-Gonzalez JF, et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A. 2008;105: 7552-7557.
18. Salazar-Gonzalez JF, Salazar MG, Keele BF, et al. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med. 2009;206: 1273-1289.
19. Ho SH, Tasca S, Shek L, et al. Coreceptor switch in R5-tropic simian/human immunodeficiency virus-infected macaques. J Virol. 2007;81: 8621-8633.
20. Ren W, Tasca S, Zhuang K, et al. Different tempo and anatomic location of dual-tropic and X4 virus emergence in a model of R5 simian-human immunodeficiency virus infection. J Virol. 2010;84:340-351.
21. Shakirzyanova M, Tsai L, Ren W, et al. Pathogenic consequences of vaginal infection with CCR5-tropic simian-human immunodeficiency virus SHIVSF162P3N. J Virol. 2012;86:9432-9442.
22. Stephen M, Smith BH, Russo C, et al. Retrospective analysis of viral load and SIV antibody responses in rhesus macaques infected with pathogenic SIV: predictive value for disease progression. AIDS Res Hum Retroviruses. 1999;15:1691-1701.
23. Mattapallil JJ, Douek DC, Hill B, et al. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature. 2005;434:1093-1097.
24. Ostrowski MA, Justement SJ, Catanzaro A, et al. Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals. J Immunol. 1998;161:3195-3201.
25. Reynes J, Portales P, Segondy M, et al. CD4 T cell surface CCR5 density as a host factor in HIV-1 disease progression. AIDS. 2001;15: 1627-1634.
26. Baroncelli S, Negri DRM, Michelini Z, et al. Macaca mulatta, fascicularis and nemestrina in AIDS vaccine development. Expert Rev Vaccines. 2008;7:1419-1434.
27. Joag SV, Stephens EB, Adams RJ, et al. Pathogenesis of SIVmac infection in Chinese and Indian rhesus macaques: effects of splenectomy on virus burden. Virology. 1994;200:436-446.
28. Ling B, Veazey RS, Luckay A, et al. SIV(mac) pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans. AIDS. 2002;16:1489-1496.
29. Marthas ML, Lu D, Penedo MC, et al. Titration of an SIVmac251 stock by vaginal inoculation of Indian and Chinese origin rhesus macaques: transmission efficiency, viral loads, and antibody responses. AIDS Res Hum Retroviruses. 2001;17:1455-1466.
30. Reimann KA, Parker RA, Seaman MS, et al. Pathogenicity of simianhuman immunodeficiency virus SHIV-89.6P and SIVmac is attenuated in cynomolgus macaques and associated with early T-lymphocyte responses. J Virol. 2005;79:8878-8885.
31. Trichel AM, Rajakumar PA, Murphey-Corb M. Species-specific variation in SIV disease progression between Chinese and Indian subspecies of rhesus macaque. J Med Primatol. 2002;31:171-178.
32. Monceaux V, Fang RHT, Cumont MC, et al. Distinct cycling CD4+- and CD8+-T-cell profiles during the asymptomatic phase of simian immunodeficiency virus SIVmac251 infection in rhesus macaques. J Virol. 2003; 77:10047-10059.
33. Monceaux V, Viollet L, F Petit, et al. CD8+ T cell dynamics during primary simian immunodeficiency virus infection in macaques: relationship of effector cell differentiation with the extent of viral replication. J Immunol. 2005;174:6898-6908.
34. Monceaux V, Viollet L, Petit F, et al. CD4+ CCR5+ T-cell dynamics during simian immunodeficiency virus infection of Chinese rhesus macaques. J Virol. 2007;81:13865-13875.
35. Lifson JD, Nowak MA, Goldstein S, et al. The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection. J Virol. 1997;71:9508-9514.
36. Mellors JW, Rinaldo CR, Gupta P, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 1996;272: 1167-1170.
37. Ling B, Veazey RS, Hart M, et al. Early restoration of mucosal CD4 memory CCR5 T cells in the gut of SIV-infected rhesus predicts long term non-progression. AIDS. 2007;21:2377-2385.
38. Degenhardt JD, de Candia P, Chabot A, et al. Copy number variation of CCL3-like genes affects rate of progression to simian-AIDS in rhesus macaques (Macaca mulatta). PLoS Genet. 2009;5:e1000346.
39. Xia H-J, Zhang G-H, Ma J-P, et al. Dendritic cell subsets dynamics and cytokine production in SIVmac239-infected Chinese rhesus macaques. Retrovirology. 2010;7:102.
40. Kirmaier A, Wu F, Newman RM, et al. TRIM5 suppresses cross-species transmission of a primate immunodeficiency virus and selects for emergence of resistant variants in the new species. PLoS Biol. 2010;8: e1000462.
41. Karl J, Wiseman R, Campbell K, et al. Identification of MHC class I sequences in Chinese-origin rhesus macaques. Immunogenetics. 2008;60: 37-46.
42. Wiseman RW, Karl JA, Bimber BN, et al. Major histocompatibility complex genotyping with massively parallel pyrosequencing. Nat Med. 2009;15:1322-1326.
43. Solomon C, Southwood S, Hoof I, et al. The most common Chinese rhesus macaque MHC class I molecule shares peptide binding repertoire with the HLA-B7 supertype. Immunogenetics. 2010;62:451-464.
44. Wambua D, Henderson R, Solomon C, et al. SIV-infected Chinese-origin rhesus macaques express specific MHC class I alleles in either elite controllers or normal progressors. J Med Primatol. 2011;40:244-247.
45. Ma X, Tang LH, Qu LB, et al. Identification of 17 novel major histocompatibility complex-A alleles in a population of Chinese-origin rhesus macaques. Tissue Antigens. 2009;73:184-187.
46. Benson J, Chougnet C, Robert-Guroff M, et al. Recombinant vaccineinduced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure. J Virol. 1998;72:4170-4182.
47. Chenine AL, Siddappa NB, Kramer VG, et al. Relative transmissibility of an R5 clade C simian-human immunodeficiency virus across different mucosae in macaques parallels the relative risks of sexual HIV-1 transmission in humans via different routes. J Infect Dis. 2010;201: 1155-1163.
48. Greenier JL, Miller CJ, Lu D, et al. Route of simian immunodeficiency virus inoculation determines the complexity but not the identity of viral variant populations that infect rhesus macaques. J Virol. 2001;75: 3753-3765.
49. Miller CJ, Marthas M, Greenier J, et al. In vivo replication capacity rather than in vitro macrophage tropism predicts efficiency of vaginal transmission of simian immunodeficiency virus or simian/human immunodeficiency virus in rhesus macaques. J Virol. 1998;72:3248-3258.
50. ten Haaft P, Almond N, Biberfeld G, et al. Comparison of early plasma RNA loads in different macaque species and the impact of different routes of exposure on SIV/SHIV infection. J Med Primatol. 2001;30:207-214.
51. Miller CJ, Marthas M, Torten J, et al. Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia. J Virol. 1994;68:6391-6400.
52. Polacino P, Larsen K, Galmin L, et al. Differential pathogenicity of SHIVSF162 P4 infection in pig-tailed and rhesus macaques. J Med Primatol. 2008;37:13-23.